ZIVO
Zivo Bioscience, Inc.
$4.83
+0.08 (+1.68%)
At close · Jul 10
Market Cap
$18.78M
Shares
3,888,595
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$4.83
Open$4.50
Day$3.80–4.83
52W$1.11–19.65
Avg vol 30d987
Short int8K · 0.2% float · 2.7d
Short vol8%
DataJan 2020–Jul 2026
Filing10-Q · Nov 14
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Nov 14, 2025
Equibles Rating
blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Bullish
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 15 · calm
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−40%
below
Price vs 50-day avg
+21%
above
RSI (14)
57
neutral
MACD trend
Positive
52-week position
20%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+43%
trailing
6-month return
−36%
trailing
YTD return
−44%
this year
Relative strength
−45%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $4 › 200d $8 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Accumulating
Net +$200.0K over 90 days · 0% sells
Short interest
Falling
0.21% of float · ▼ -0.5% MoM · 2.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Squeeze score
53
elevated · 0–100
Fundamentals
Revenue growth
+469%
Y/Y
Gross margin
31%
contracting
EPS growth
+8%
Y/Y
Free cash flow
$-4.3M
Balance sheet
$1.8M
net cash
Quant / Vol
risk profile
Volatility
183%
annualized · 1-yr
Max drawdown
−94%
past year
ATR
11.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−40%
Bearish
Price vs 50-day avg
+21%
Bullish
RSI (14)
57
Neutral
MACD trend
Positive
Bullish
52-week position
20%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $4 › 200d $8 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Accumulating
Net +$200.0K over 90 days · 0% sells
Short interest
Falling
0.21% of float · ▼ -0.5% MoM · 2.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
52-wk low $1
Now $5 · 20%
52-wk high $20
vs 200-day avg -40%
vs 50-day avg +21%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ZIVO
this stock
Zivo Bioscience, Inc.
|
$18.78M | -44.5% | +468.6% | — | 0.2% |
|
ONC
BeOne Medicines Ltd.
|
$431.70B | -1.7% | +22179.2% | 878.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$123.19B | +7.1% | +46.2% | 28.8 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.67B | -13.8% | +20.8% | 16.2 | 3.3% |
|
ARGX
Argenx SE
|
$54.85B | +4.4% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Smart Money
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ZIVO | -8.0% | +42.9% | -35.7% | +19.9% | -44.5% |
| SPY | +1.4% | +4.1% | +9.1% | +1.1% | +10.7% |
| vs SPY | -9.4% | +38.8% | -44.8% | +18.8% | -55.2% |